drugset / Trial / NCT04592016

Evaluate the Ability of dOFM for BE Testing of Topically Applied Diclofenac Sodium Products in Healthy Subjects

NCT04592016

Non-randomizedSequentialOpen-labelOther

Summary

This will be a single center, open label, exploratory research study to assess the dermal pharmacokinetic (PK) profile of three marketed diclofenac products in 26 healthy volunteers using dermal open flow microperfusion (dOFM). This clinical study aims to assess bioequivalence (BE) of three different diclofenac products.

Timeline

Start
2020-10-08
Primary completion
2021-08-11
Completion
2021-08-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 1 % Topical
Subject Diclofenac Other / unclassified 2 % Topical

Indications

No indication recorded.